Deep Track Capital, LP
GREENWICH, CT · CIK 1856083 · 13F filing filed 2022-08-12
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyGreenwich, CT
$1.4bn
reported value
-6.6% vs Q1 2022
49positions
49.8%in top 10
6 new
22 added
11 reduced
6 sold out
vs Q1 2022
Options: 1 call positions ($72.9m notional), 1 put positions ($2.1m notional) – listed below, not included above.
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS IN GBT | $116.5m8.06% | Added +1.3m |
| NOVOCURE LTD NVCR | $93.2m6.45% | Added +341.3k |
| TRAVERE THERAPEUTICS INC TVTX | $86.8m6.00% | Added +446.2k |
| JAZZ PHARMACEUTICALS PLC JAZZ | $78.0m5.39% | Reduced -17.1k |
| KURA ONCOLOGY INC KURA | $67.8m4.69% | Added +286.0k |
| MADRIGAL PHARMACEUTICALS INC MDGL | $64.8m4.48% | Added +119.0k |
| CHINOOK THERAPEUTICS INC ADRO | $60.0m4.15% | Added +430.1k |
| BIOMARIN PHARMACEUTICAL INC BMRN | $54.2m3.75% | New |
| FATE THERAPEUTICS INC FATE | $50.0m3.46% | Added +18.0k |
| BICYCLE THERAPEUTICS PLC BCYC | $48.7m3.36% | Added +1.0m |
| BEAM THERAPEUTICS INC BEAM | $48.4m3.35% | Added +486.2k |
| IVERIC BIO INC OPHT | $43.3m2.99% | Unchanged |
| AGENUS INC COM NEW | $43.1m2.98% | Added +8.2m |
| ESPERION THERAPEUTICS INC NE ESPR | $38.2m2.64% | Unchanged |
| REPARE THERAPEUTICS INC RPTX | $37.9m2.62% | Added +43.6k |
| NUVATION BIO INC NUVB | $37.2m2.57% | Added +10.3m |
| IMMUNOVANT INC IMVT | $36.9m2.55% | Added +2.2m |
| NKARTA INC NKTX | $34.7m2.40% | Added +701.0k |
| NURIX THERAPEUTICS INC NRIX | $30.9m2.13% | New |
| FORMA THERAPEUTICS HLDGS INC SHS | $27.9m1.93% | Added +2.4m |
| TRICIDA INC TCDA | $26.4m1.83% | Added +79.4k |
| ACADIA PHARMACEUTICALS INC ACAD | $24.4m1.69% | New |
| DYNE THERAPEUTICS INC DYN | $24.0m1.66% | Unchanged |
| 4D MOLECULAR THERAPEUTICS IN FDMT | $21.9m1.52% | Added +691.8k |
| KEROS THERAPEUTICS INC KROS | $20.4m1.41% | Reduced -640.8k |
| CRINETICS PHARMACEUTICALS IN CRNX | $19.6m1.36% | Reduced -488.7k |
| KALVISTA PHARMACEUTICALS INC KALV | $17.9m1.24% | Added +94.2k |
| DICE THERAPEUTICS INC COM | $16.2m1.12% | Reduced -207.1k |
| INOZYME PHARMA INC COM | $15.5m1.07% | New |
| SCHRODINGER INC SDGR | $14.8m1.03% | New |
| ACUMEN PHARMACEUTICALS INC ABOS | $14.6m1.01% | Added +500.9k |
| ANAPTYSBIO INC ANAB | $13.7m0.94% | Added +113.8k |
| VIRIDIAN THERAPEUTICS INC VRDN | $13.5m0.94% | Unchanged |
| ADICET BIO INC COM | $13.0m0.90% | New |
| JOUNCE THERAPEUTICS INC JNCE | $12.9m0.89% | Unchanged |
| SILENCE THERAPEUTICS PLC SLN | $11.3m0.78% | Unchanged |
| RELMADA THERAPEUTICS INC RLMD | $9.5m0.66% | Added +397.9k |
| HOOKIPA PHARMA INC COM | $8.2m0.57% | Unchanged |
| CENTURY THERAPEUTICS INC IPSC | $7.8m0.54% | Reduced -1.8k |
| MAGENTA THERAPEUTICS INC COM | $6.4m0.44% | Unchanged |
| ASSEMBLY BIOSCIENCES INC COM | $6.3m0.44% | Unchanged |
| SAGE THERAPEUTICS INC SAGE | $5.5m0.38% | Reduced -503.2k |
| PASSAGE BIO INC COM | $5.5m0.38% | Reduced -1.1m |
| GH RESEARCH PLC GHRS | $5.0m0.34% | Unchanged |
| FULCRUM THERAPEUTICS INC FULC | $4.9m0.34% | Added +350.0k |
| GRITSTONE BIO INC GRTS | $4.2m0.29% | Reduced -1.3m |
| TENAYA THERAPEUTICS INC TNYA | $2.7m0.19% | Reduced -63.1k |
| ATYR PHARMA INC ATYR | $823.0k0.06% | Reduced -737.7k |
| VIGIL NEUROSCIENCE INC VIGL | $796.0k0.06% | Reduced -80.7k |
Sold out since Q1 2022
| Security | Value then |
|---|---|
| ALNYLAM PHARMACEUTICALS INC ALNY | $75.7m463.7k shares |
| ENANTA PHARMACEUTICALS INC ENTA | $14.1m198.7k shares |
| PROMETHEUS BIOSCIENCES INC | $9.3m245.0k shares |
| VERVE THERAPEUTICS INC | $2.3m102.3k shares |
| AUTOLUS THERAPEUTICS PLC AUTL | $1.6m382.6k shares |
| RAFAEL HLDGS INC RFL | $261.0k104.2k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| ALNYLAM PHARMACEUTICALS INC ALNY · Call | $72.9m499.9k shares | New |
| PROTAGONIST THERAPEUTICS INC PTGX · Put | $2.1m260.5k shares | Added |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on. The largest 25 of 28.
| Company | Stake |
|---|---|
| LB PHARMACEUTICALS INC LBRX · 13D · filed 2026-02-10 | 11.7%≈ $108.8m |
| ALTIMMUNE INC ALT · 13G · filed 2026-04-30 | 10.0%≈ $59.0m |
| PROMIS NEUROSCIENCES INC PMN · 13G · filed 2026-02-06 | 10.0%≈ $11.9m |
| VERASTEM INC VSTM · 13G · filed 2025-11-21 | 10.0%≈ $29.5m |
| COMPASS PATHWAYS PLC CMPS · 13G · filed 2025-01-17 | 10.0% |
| RAPT THERAPEUTICS INC 13G · filed 2024-12-23 | 9.9% |
| MOONLAKE IMMUNOTHERAPEUTICS MLTX · 13G · filed 2026-08-14 | 9.7%≈ $155.7m |
| OCULAR THERAPEUTIX INC OCUL · 13G · filed 2026-05-15 | 9.5%≈ $204.7m |
| MAZE THERAPEUTICS INC MAZE · 13G · filed 2025-08-14 | 9.0%≈ $117.8m |
| IMMUNIC INC 13G · filed 2026-03-04 | 8.7% |
| ALECTOR INC ALEC · 13G · filed 2026-10-23 | 8.6%≈ $21.3m |
| TARSUS PHARMACEUTICALS INC TARS · 13G · filed 2026-05-15 | 8.5%≈ $226.6m |
| X4 PHARMACEUTICALS INC XFOR · 13G · filed 2026-08-14 | 8.3%≈ $37.6m |
| CONTEXT THERAPEUTICS INC CNTX · 13G · filed 2025-05-15 | 8.3%≈ $4.1m |
| HEMAB THERAPEUTICS HLDGS INC COAG · 13G · filed 2026-05-08 | 8.2%≈ $132.3m |
| CORMEDIX INC CRMD · 13G · filed 2026-05-15 | 7.9%≈ $49.3m |
| NURIX THERAPEUTICS INC NRIX · 13G · filed 2026-08-14 | 7.5%≈ $187.7m |
| ATENTO S A ATTO · 13G · filed 2026-08-12 | 7.5% |
| CENTURY THERAPEUTICS INC IPSC · 13G · filed 2026-01-15 | 7.3%≈ $33.0m |
| ACLARIS THERAPEUTICS INC ACRS · 13G · filed 2026-03-17 | 7.0%≈ $49.4m |
| AVALO THERAPEUTICS INC AVTX · 13G · filed 2026-08-14 | 6.9%≈ $66.7m |
| MIND MEDICINE MINDMED INC 13G · filed 2025-11-14 | 6.9% |
| ENGENE HOLDINGS INC 13G · filed 2025-11-18 | 6.7% |
| BICARA THERAPEUTICS INC BCAX · 13G · filed 2026-05-15 | 6.2%≈ $120.6m |
| ALUMIS INC ALMS · 13G · filed 2026-04-07 | 6.0%≈ $207.2m |